Niagen Bioscience, Inc.
US ˙ NasdaqCM ˙ US1710774076

SecurityNAGE / Niagen Bioscience, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership92,343 shares
Latest Disclosed Value $ 407,233
Squarepoint Ops LLC reports 42.70% decrease in ownership of NAGE / Niagen Bioscience, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 92,343 shares of Niagen Bioscience, Inc. (US:NAGE) valued at $407,233 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 161,155 shares of Niagen Bioscience, Inc.. This represents a change in shares of -42.70% during the quarter. The current value of the position is $317,660 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 92,343 -68,812 -42.70 407 -60.25 0.0005
2026-02-13 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 161,155 116,472 260.66 1,025 146.15 0.0011
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 44,683 44,683 417 0.0004
2025-08-27 2025-06-30 13F/A-1 NIAGEN BIOSCIENCE COM NEW 171077407 0 -59,070 -100.00 0 -100.00
2025-08-14 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 0 -59,070 0
2025-08-27 2025-03-31 13F/A-1 NIAGEN BIOSCIENCE COM NEW 171077407 59,070 -45,564 -43.55 408 -26.67 0.0005
2025-05-15 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 59,070 -45,564 408 0.0005
2025-02-14 2024-12-31 13F CHROMADEX COM NEW 171077407 104,634 104,634 555 0.0005
2024-08-14 2024-06-30 13F CHROMADEX COM NEW 171077407 0 -36,461 -100.00 0 -100.00
2024-05-15 2024-03-31 13F CHROMADEX COM NEW 171077407 36,461 -25,438 -41.10 127 43.18 0.0002
2024-02-14 2023-12-31 13F CHROMADEX COM NEW 171077407 61,899 3,632 6.23 89 3.53 0.0002
2023-11-14 2023-09-30 13F CHROMADEX COM NEW 171077407 58,267 19,191 49.11 85 39.34 0.0002
2023-08-14 2023-06-30 13F CHROMADEX COM NEW 171077407 39,076 21,093 117.29 61 125.93 0.0002
2023-05-15 2023-03-31 13F CHROMADEX COM NEW 171077407 17,983 17,983 28 0.0001
2022-11-14 2022-09-30 13F CHROMADEX COM NEW 171077407 0 -27,432 -100.00 0 -100.00
2022-08-15 2022-06-30 13F CHROMADEX COM NEW 171077407 27,432 27,432 46 0.0003
2022-05-16 2022-03-31 13F CHROMADEX COM NEW 171077407 0 -13,947 -100.00 0 -100.00
2022-02-14 2021-12-31 13F CHROMADEX COM NEW 171077407 13,947 13,947 52 0.0001
2021-11-15 2021-09-30 13F CHROMADEX COM NEW 171077407 0 -33,581 -100.00 0 -100.00
2021-08-16 2021-06-30 13F CHROMADEX COM NEW 171077407 33,581 17,981 115.26 331 126.71 0.0013
2021-05-17 2021-03-31 13F CHROMADEX COM NEW 171077407 15,600 -13,877 -47.08 146 3.55 0.0009
2021-02-16 2020-12-31 13F CHROMADEX COM NEW 171077407 29,477 -8,263 -21.89 141 -6.62 0.0011
2020-11-16 2020-09-30 13F CHROMADEX COM NEW 171077407 37,740 37,740 151 0.0020
2018-08-14 2018-06-30 13F CHROMADEX COM NEW 171077407 0 -55,450 -100.00 0 -100.00
2018-05-15 2018-03-31 13F CHROMADEX COM NEW 171077407 55,450 55,450 233 0.0037
2018-02-14 2017-12-31 13F CHROMADEX COM NEW 171077407 0 -30,000 -100.00 0 -100.00
2017-11-14 2017-09-30 13F CHROMADEX COM NEW 171077407 30,000 6,639 28.42 129 44.94 0.0025
2017-08-14 2017-06-30 13F CHROMADEX COM NEW 171077407 23,361 23,361 89 0.0018
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.